← Back to News

Various

Analyst Upgrades and Downgrades For the Week of October 7th

Analyst upgrades, downgrades, and more

By Justin Nugent · October 7, 2024
Analyst Upgrades and Downgrades For the Week of October 7th

October 11th

Upgrades

  • Affirm (AFRM): Wells Fargo upgraded from Equal Weight to Overweight; price target increased from $40 to $52.
  • Kinder Morgan (KMI): BofA Securities upgraded from Neutral to Buy; price target raised from $23 to $27.
  • Ferrari (RACE): JP Morgan upgraded from Neutral to Overweight; price target increased from $385 to $525.
  • United Natural Foods (UNFI): Northcoast upgraded from Neutral to Buy.

Downgrades

  • ProFrac Holding (ACDC): Stifel downgraded from Buy to Hold; price target set at $7.
  • Flywire (FLYW): Wells Fargo downgraded from Overweight to Equal Weight; price target lowered from $20 to $18.
  • General Dynamics (GD): Seaport Research Partners downgraded from Buy to Neutral.
  • General Motors (GM): DZ Bank downgraded from Buy to Hold; price target set at $49.
  • Mobileye Global (MBLY): Mizuho downgraded from Outperform to Neutral; price target slashed from $30 to $13.
  • ArcelorMittal (MT): JP Morgan downgraded from Overweight to Neutral.
  • The Duckhorn Portfolio (NAPA): RBC Capital downgraded from Outperform to Sector Perform.
  • Qorvo (QRVO): Morgan Stanley downgraded from Overweight to Equal Weight; price target lowered from $130 to $120.
  • Sociedad Quimica y Minera (SQM): JP Morgan downgraded from Overweight to Neutral; price target cut from $55 to $44.
  • Toronto-Dominion Bank (TD): RBC Capital downgraded from Outperform to Sector Perform.
  • Star Bulk Carriers (SBLK): DNB Markets downgraded from Hold to Sell.
  • HUYA (HUYA): HSBC Securities downgraded from Buy to Hold.

Coverage Initiated

  • Acadia Healthcare (ACHC): KeyBanc Capital Markets initiated coverage with Sector Weight.
  • Addus HomeCare (ADUS): KeyBanc Capital Markets initiated with Overweight and a price target of $150.
  • Alignment Healthcare (ALHC): KeyBanc Capital Markets initiated with Sector Weight.
  • Amazon (AMZN): Pivotal Research Group initiated coverage with Buy ($260) and Scotiabank initiated with Sector Outperform ($245).
  • ANI Pharma (ANIP): Piper Sandler initiated with Overweight and a price target of $68.
  • Ardent Health Partners (ARDT): KeyBanc Capital Markets initiated with Overweight and a price target of $24.
  • Axos Financial (AX): Needham initiated coverage with Buy and a price target of $82.
  • Encompass Health (EHC): KeyBanc Capital Markets initiated with Overweight and a price target of $115.
  • Evolent Health (EVH): KeyBanc Capital Markets initiated with Overweight and a price target of $35.
  • Alphabet (GOOG): Scotiabank initiated coverage with Sector Outperform ($212).
  • MercadoLibre (MELI): Redburn Atlantic initiated with Buy and a price target of $2800.
  • Monopar Therapeutics (MNPR): Rodman & Renshaw initiated with Buy and a price target of $50.
  • Nurix Therapeutics (NRIX): Jefferies initiated with Buy and a price target of $41.
  • Oruka Therapeutics (ORKA): Stifel initiated with Buy and a price target of $49.
  • Privia Health (PRVA): KeyBanc Capital Markets initiated with Overweight and a price target of $23.
  • Tenet Healthcare (THC): KeyBanc Capital Markets initiated with Overweight and a price target of $200.
  • UnitedHealth (UNH): KeyBanc Capital Markets initiated with Overweight and a price target of $675.
  • V.F. Corp (VFC): Goldman Sachs initiated with Neutral and a price target of $20.
  • V2X (VVX): Robert W. Baird initiated with Outperform and a price target of $75.
  • Cardlytics (CDLX): Evercore ISI initiated with In-line and a price target of $4.

October 9th

Upgrades:

  • Affirm (AFRM): Morgan Stanley from Underweight to Equal-Weight; PT $22 to $37.
  • Home Depot (HD): Loop Capital from Hold to Buy; PT $360 to $460.
  • Inter & Co (INTR): JP Morgan from Neutral to Overweight; PT $7.5 to $8.5.
  • Lowe’s (LOW): Loop Capital from Hold to Buy; PT $250 to $300.
  • LPL Financial (LPLA): Wells Fargo from Equal Weight to Overweight; PT $235 to $285.
  • Southwest Air (LUV): Jefferies from Underperform to Hold; PT $24 to $32.
  • MSCI (MSCI): Redburn Atlantic from Neutral to Buy; PT not specified.
  • Norwegian Cruise Line (NCLH): Citigroup from Neutral to Buy; PT $20 to $30.
  • Raymond James (RJF): JMP Securities from Market Perform to Market Outperform; PT not specified.
  • Saia (SAIA): Wolfe Research from Peer Perform to Outperform; PT $511.
  • Valero Energy (VLO): Wells Fargo from Equal Weight to Overweight; PT $172 to $165.
  • VNET Group (VNET): HSBC Securities from Hold to Buy; PT $5.2.

Downgrades:

  • ArcBest (ARCB): Wolfe Research from Outperform to Peer Perform; PT not specified.
  • BP (BP): Exane BNP Paribas from Outperform to Neutral; PT not specified.
  • Blackstone (BX): Piper Sandler from Overweight to Neutral; PT $149.
  • Ciena (CIEN): Exane BNP Paribas from Outperform to Neutral; PT $59 to $67.
  • Commercial Metals (CMC): Wolfe Research from Outperform to Peer Perform; PT not specified.
  • FactSet (FDS): Redburn Atlantic from Neutral to Sell; PT $420 to $380.
  • Morningstar (MORN): Redburn Atlantic from Buy to Neutral; PT $340.
  • Vale S.A. (VALE): Wolfe Research from Peer Perform to Underperform; PT not specified.
  • Exxon Mobil (XOM): Exane BNP Paribas from Neutral to Underperform; PT $105.
  • ING Groep (ING): Deutsche Bank from Buy to Hold; PT not specified.

New Coverage Initiated:

  • AFC Gamma (AFCG): Seaport Research Partners; Buy; PT $13.
  • Aflac (AFL): TD Cowen; Hold; PT $102.
  • ArcBest (ARCB): Citigroup; Neutral; PT $111.
  • Blue Bird (BLBD): BTIG Research; Buy; PT $55.
  • C.H. Robinson (CHRW): Citigroup; Neutral; PT $115.
  • Chewy (CHWY): TD Cowen; Buy; PT $38.
  • Canadian Nat’l Rail (CNI): Citigroup; Neutral; PT $125.
  • Canadian Pacific Kansas City Ltd. (CP): Citigroup; Buy; PT $97.
  • Corebridge Financial (CRBG): TD Cowen; Buy; PT $35.
  • Crocs (CROX): Guggenheim; Buy; PT $182.
  • CSX (CSX): Citigroup; Buy; PT $42.
  • Deckers Outdoor (DECK): Guggenheim; Neutral; PT not specified.
  • FedEx (FDX): Citigroup; Buy; PT $301.
  • Shift4 Payments (FOUR): Barclays; Overweight; PT $120.
  • G-III Apparel (GIII): Guggenheim; Buy; PT $36.
  • Globe Life (GL): TD Cowen; Buy; PT $150.
  • GitLab (GTLB): Morgan Stanley; Overweight; PT $70.
  • GXO Logistics (GXO): Citigroup; Buy; PT $60.
  • Hewlett Packard Enterprise (HPE): Deutsche Bank; Hold; PT $22.
  • J.B. Hunt Transport (JBHT): Citigroup; Buy; PT $201.
  • Knight-Swift (KNX): Citigroup; Neutral; PT $55.
  • Kyverna Therapeutics (KYTX): Rodman & Renshaw; Buy; PT $16.
  • Lincoln National (LNC): TD Cowen; Hold; PT $34.
  • MetLife (MET): TD Cowen; Buy; PT $97.
  • Nkarta (NKTX): Rodman & Renshaw; Buy; PT $14.
  • Norfolk Southern (NSC): Citigroup; Buy; PT $294.
  • Old Dominion (ODFL): Citigroup; Neutral; PT $206.
  • PACS Group (PACS): UBS; Buy; PT $50.
  • Primerica (PRI): TD Cowen; Buy; PT $314.
  • Prudential (PRU): TD Cowen; Hold; PT $130.
  • Reddit (RDDT): Jefferies; Buy; PT $90.
  • Reinsurance Group of America (RGA): TD Cowen; Hold; PT $235.
  • RXO, Inc. (RXO): Citigroup; Buy; PT $33.
  • Saia (SAIA): Citigroup; Buy; PT $518.
  • Schneider National (SNDR): Citigroup; Neutral; PT $29.
  • Sound Point Meridian Capital (SPMC): B. Riley Securities; Buy; PT $22.5.
  • TFI International (TFII): Citigroup; Buy; PT $159.
  • Union Pacific (UNP): Citigroup; Neutral; PT $264.
  • UPS (UPS): Citigroup; Buy; PT $162.
  • Werner Enterprises (WERN): Citigroup; Sell; PT $34.
  • XPO, Inc. (XPO): Citigroup; Buy; PT $127.
  • New York Times (NYT): Deutsche Bank; Buy; PT $65.
  • RLI Corp (RLI): Wolfe Research; Outperform; PT $182.
  • SAB BIO (SABS): Craig Hallum; Buy; PT $11.
  • Steelcase (SCS): Noble Capital Markets; Outperform; PT not specified.
  • Bitdeer Technologies (BTDR): Northland Capital; Outperform; PT $13.
  • Con Edison (ED): Jefferies; Hold; PT $108.

OCTOBER 8TH:

Upgrades

  • Affirm (AFRM): BTIG Research upgraded from Neutral to Buy; Price Target: $68
  • CEMEX S.A. (CX): RBC Capital Markets upgraded from Underperform to Sector Perform; Price Target revised from $9 to $6.5
  • Humana (HUM): Bernstein upgraded from Market Perform to Outperform; Price Target: $308
  • Sun Country Airlines (SNCY): Wolfe Research upgraded from Peer Perform to Outperform; Price Target: $14
  • Ubisoft (UBSFY): UBS upgraded from Sell to Neutral
  • UWM Holdings (UWMC): Barclays upgraded from Underweight to Equal Weight; Price Target revised from $6 to $8
  • Waters (WAT): Jefferies upgraded from Hold to Buy; Price Target revised from $355 to $415
  • Wells Fargo (WFC): Wolfe Research upgraded from Peer Perform to Outperform; Price Target: $65
  • McDonald’s (MCD): Argus upgraded from Hold to Buy
  • Cassava Sciences (SAVA): H.C. Wainwright upgraded from Neutral to Buy; Price Target: $116

Downgrades

  • American Express (AXP): BTIG Research downgraded from Neutral to Sell; Price Target: $230
  • American Express (AXP): HSBC downgraded from Buy to Hold; Price Target revised from $265 to $270
  • Anheuser-Busch InBev (BUD): TD Cowen downgraded from Buy to Hold
  • CME Group (CME): Redburn Atlantic downgraded from Buy to Neutral; Price Target: $244
  • Frontier Communications Parent (FYBR): TD Cowen downgraded from Buy to Hold
  • Microsoft (MSFT): Oppenheimer downgraded from Outperform to Perform
  • OneMain Holdings (OMF): Barclays downgraded from Overweight to Equal Weight; Price Target revised from $52 to $46
  • Otis Worldwide (OTIS): Wolfe Research downgraded from Outperform to Peer Perform
  • Qualcomm (QCOM): KeyBanc Capital Markets downgraded from Overweight to Sector Weight
  • Constellation Brands (STZ): TD Cowen downgraded from Buy to Hold; Price Target revised from $300 to $270
  • Synaptics (SYNA): KeyBanc Capital Markets downgraded from Overweight to Sector Weight
  • Trip.com Group (TCOM): HSBC downgraded from Buy to Hold

Coverage Initiated

  • Abbott Labs (ABT): Oppenheimer rated Outperform; Price Target: $130
  • Arcellx (ACLX): Redburn Atlantic rated Buy; Price Target: $109
  • Bicara Therapeutics (BCAX): Multiple firms rated Buy or Overweight
  • CrowdStrike (CRWD): Exane BNP Paribas rated Neutral; Price Target: $285
  • Datadog (DDOG): Exane BNP Paribas rated Outperform; Price Target: $150
  • First National (FXNC): Hovde Group rated Outperform; Price Target: $22
  • Howmet Aerospace (HWM): Susquehanna rated Positive; Price Target: $120
  • Palo Alto Networks (PANW): Exane BNP Paribas rated Outperform; Price Target: $410

OCTOBER 7TH:

Upgrades

  • Ally Financial (ALLY): JP Morgan, Neutral to Overweight, Price Target $46 to $40
  • Alibaba (BABA): Macquarie, Neutral to Outperform, Price Target $145
  • Couchbase (BASE): Barclays, Equal Weight to Overweight, Price Target $19
  • Canadian National Railway (CNI): Wells Fargo, Equal Weight to Overweight, Price Target $125
  • Coty (COTY): Jefferies, Hold to Buy, Price Target $11 to $12
  • Campbell Soup (CPB): Bernstein, Market Perform to Outperform, Price Target $55 to $58
  • Coupang (CPNG): Bernstein, Underperform to Outperform, Price Target $30
  • Dynatrace (DT): Barclays, Equal Weight to Overweight, Price Target $52 to $64
  • Elastic (ESTC): Barclays, Equal Weight to Overweight, Price Target $90 to $95
  • Frontline (FRO): BTIG Research, Neutral to Buy, Price Target $30
  • Integra (IART): BTIG Research, Sell to Neutral
  • Netflix (NFLX): Piper Sandler, Neutral to Overweight, Price Target $650 to $800
  • NXP Semiconductors (NXPI): UBS, Neutral to Buy, Price Target $275 to $285
  • Pinduoduo (PDD): Macquarie, Neutral to Outperform, Price Target $126 to $224
  • Tyler Technologies (TYL): Barclays, Equal Weight to Overweight, Price Target $577 to $700
  • Western Alliance Bancorp (WAL): Deutsche Bank, Hold to Buy, Price Target $83 to $101
  • Mohawk Industries (MHK): Wells Fargo, Underweight to Equal Weight, Price Target $140 to $160
  • Gilead Sciences (GILD): Wells Fargo, Equal Weight to Overweight, Price Target $78 to $100
  • Air Products (APD): Evercore ISI, In-line to Outperform, Price Target $305 to $365
  • Air Products (APD): Vertical Research, Hold to Buy, Price Target $336
  • Air Products (APD): Jefferies, Hold to Buy, Price Target $295 to $364
  • Ubisoft (UBSFY): Bernstein, Underperform to Market Perform

Downgrades

  • Apple (AAPL): Jefferies, Buy to Hold, Price Target $205 to $212.92
  • AMN Healthcare (AMN): BofA Securities, Neutral to Underperform, Price Target $65 to $48
  • Amazon (AMZN): Wells Fargo, Overweight to Equal Weight, Price Target $225 to $183
  • American Express (AXP): JP Morgan, Overweight to Neutral, Price Target $268 to $286
  • Brookdale Senior Living (BKD): BofA Securities, Neutral to Underperform, Price Target $7.75 to $6
  • Celanese (CE): KeyBanc Capital Markets, Overweight to Sector Weight
  • Ciena (CIEN): JP Morgan, Overweight to Neutral, Price Target $65
  • Comerica (CMA): BofA Securities, Neutral to Underperform, Price Target $55 to $52
  • Concentra Group Holdings Parent (CON): BofA Securities, Buy to Neutral, Price Target $30.5 to $24
  • Charles River (CRL): Evercore ISI, Outperform to In-line, Price Target $225 to $190
  • Centuri Holdings (CTRI): JP Morgan, Neutral to Underweight, Price Target $19 to $16
  • Sprinklr (CXM): Barclays, Overweight to Underweight, Price Target $10 to $7
  • DuPont (DD): Barclays, Equal Weight to Underweight, Price Target $88 to $84
  • Denali Therapeutics (DNLI): Cantor Fitzgerald, Overweight to Neutral
  • Evotec SE (EVO): Jefferies, Buy to Hold
  • Garmin (GRMN): Morgan Stanley, Equal Weight to Underweight, Price Target $155 to $138
  • Hershey Foods (HSY): Bernstein, Outperform to Market Perform, Price Target $230 to $205
  • Hershey Foods (HSY): UBS, Buy to Neutral, Price Target $226 to $209
  • Humana (HUM): Jefferies, Buy to Hold, Price Target $519 to $253
  • Deckers Outdoor (DECK): Seaport Research Partners, Buy to Neutral
  • Intapp (INTA): Barclays, Overweight to Equal Weight, Price Target $44
  • Lamb Weston (LW): JP Morgan, Overweight to Neutral, Price Target $63 to $68
  • Mobileye Global (MBLY): JP Morgan, Neutral to Underweight, Price Target $16 to $10
  • Netflix (NFLX): Barclays, Equal Weight to Underweight, Price Target $550
  • Sherwin-Williams (SHW): KeyBanc Capital Markets, Overweight to Sector Weight
  • SITE Centers (SITC): KeyBanc Capital Markets, Overweight to Sector Weight
  • Constellation Brands (STZ): BofA Securities, Buy to Neutral, Price Target $300 to $255
  • U.S. Physical Therapy (USPH): BofA Securities, Buy to Neutral, Price Target $114 to $90
  • Lennar (LEN): Wells Fargo, Overweight to Equal Weight, Price Target $205 to $190
  • KB Home (KBH): Wells Fargo, Equal Weight to Underweight, Price Target $80 to $83
  • Immunocore (IMCR): Guggenheim, Buy to Neutral
  • Humana (HUM): TD Cowen, Buy to Hold, Price Target $402 to $261
  • Halozyme Therapeutics (HALO): Wells Fargo, Overweight to Equal Weight, Price Target $58 to $62
  • Ametek (AME): TD Cowen, Hold to Sell
  • Portillo’s (PTLO): Stephens, Overweight to Equal Weight, Price Target $13
  • Vista Outdoor (VSTO): Monness Crespi & Hardt, Buy to Neutral

Coverage Initiated

  • Applied Industrial (AIT): BofA Securities, Neutral, Price Target $232
  • Avery Dennison (AVY): Barclays, Overweight, Price Target $250
  • Celldex Therapeutics (CLDX): Citigroup, Buy, Price Target $70
  • Clover Health (CLOV): UBS, Neutral, Price Target $4
  • Curbline Properties (CURB): KeyBanc Capital Markets, Sector Weight
  • DiaMedica Therapeutics (DMAC): H.C. Wainwright, Buy, Price Target $7
  • Fastenal (FAST): BofA Securities, Buy, Price Target $85
  • Foot Locker (FL): Gordon Haskett, Accumulate, Price Target $27
  • Grainger (GWW): BofA Securities, Underperform, Price Target $925
  • Immatics N.V. (IMTX): Piper Sandler, Overweight, Price Target $19
  • Uranium Royalty (UROY): B. Riley Securities, Buy, Price Target $3.5
  • MasTec (MTZ): JP Morgan, Overweight, Price Target $153
  • Oruka Therapeutics (ORKA): H.C. Wainwright, Buy, Price Target $45
  • Oscar Health (OSCR): UBS, Neutral, Price Target $23
  • Dave & Buster’s (PLAY): The Benchmark Company, Hold
  • Primoris Services (PRIM): JP Morgan, Overweight, Price Target $71
  • Quanta Services (PWR): JP Morgan, Neutral, Price Target $297
  • Sila Realty Trust (SILA): Truist, Buy, Price Target $29
  • Solventum Corporation (SOLV): Piper Sandler, Neutral, Price Target $71
  • Vertiv (VRT): Jefferies, Buy, Price Target $125
  • Westrock Coffee Company (WEST): Truist, Buy, Price Target $10
  • Zevra Therapeutics (ZVRA): Guggenheim, Buy, Price Target $20
  • Serve Robotics (SERV): Seaport Research Partners, Buy, Price Target $12
  • TrueCar (TRUE): Lake Street, Buy, Price Target $6
  • South Bow Corporation (SOBO): Wolfe Research, Outperform
  • American Water Works (AWK): Jefferies, Underperform, Price Target $124
  • Essential Utilities (WTRG): Jefferies, Buy, Price Target $44
  • Nintendo (NTDOY): TD Cowen, Buy